Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Conditional expansion of Sepracor and Aventis eszopiclone agreement

July 15, 2004

Prous Science announces publication of a comprehensive review on insomnia

July 15, 2004

A triple TCR peptide vaccine shows promise in patients with multiple sclerosis

July 15, 2004

Pain Therapeutics' efforts in neuropathic pain supported by NIH grant

July 14, 2004

Grant for Alzheimer's diagnostic work at Samaritan and Georgetown University

July 14, 2004

CRF1 receptor antagonists for anxiety, affective disorders, etc.

July 13, 2004

Salbutamol reported to improve muscle strength in children with congenital myopathies

July 13, 2004

Benzoxazinone derivatives for the treatment of CNS and other disorders

July 13, 2004

Clinical evidence for the efficacy of pregabalin in painful diabetic neuropathy

July 13, 2004

New phase II trial for M-40403

July 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...